A. Edwards

发表

Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection.

R. Phillips, P. Goulder, A. McMichael, 1996, AIDS research and human retroviruses.

Differential selection pressure exerted on HIV by CTL targeting identical epitopes but restricted by distinct HLA alleles from the same HLA supertype

B. Walker, J. Mullins, C. Brander, 2006, The Journal of Immunology.

Low natural killer‐cell activity and immunoglobulin levels associated with smoking in human subjects

P. Hersey, A. Edwards, M. Ferson, 1979, International journal of cancer.

Alteration of T cell subsets and induction of suppressor T cell activity in normal subjects after exposure to sunlight.

P. Hersey, A. Edwards, E. Hasic, 1983, Journal of immunology.

Differential Escape Patterns within the Dominant HLA-B*57:03-Restricted HIV Gag Epitope Reflect Distinct Clade-Specific Functional Constraints

B. Walker, R. Haubrich, M. John, 2014, Journal of Virology.

IMMUNOLOGICAL EFFECTS OF SOLARIUM EXPOSURE

P. Hersey, A. Edwards, W. McCarthy, 1983, The Lancet.

Efﬁcacious Early Antiviral Activity of HIV Gag- and Pol-Speciﬁc HLA-B*2705-Restricted CD8 (cid:1) T Cells (cid:1)

S. Buus, J. Prado, R. Phillips, 2010 .

Induction of cytotoxic activity in human lymphocytes against autologous and allogeneic melanoma cells in vitro by culture with interleukin 2

P. Hersey, A. Edwards, W. McCarthy, 1981, International journal of cancer.

Antigens on melanoma cells detected by leukocyte dependent antibody assays of human melanoma antisera

P. Hersey, A. Edwards, M. Honeyman, 1976, International journal of cancer.

Specificity of cell‐mediated cytotoxicity against human melanoma lines: Evidence for “non‐specific” killing by activated T‐cells

P. Hersey, A. Edwards, E. Adams, 1975, International journal of cancer.

Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS

Martin A. Nowak, Robert A. Colbert, Sarah Rowland-Jones, 1997, Nature Medicine.

Identification of a novel HLA-B*2705-restricted cytotoxic T-lymphocyte epitope within a conserved region of HIV-1 Nef.

R. Phillips, P. Goulder, A. McMichael, 1997, AIDS.

Clearance rates and systemic effects of intravenously administered interleukin 2 (IL-2) containing preparations in human subjects.

P. Hersey, A. Edwards, P. Ruell, 1983, British Journal of Cancer.

P. Hersey, A. Edwards, W. McCarthy, 1982 .

Low natural-killer-cell activity in familial melanoma patients and their relatives.

P. Hersey, A. Edwards, M. Honeyman, 1979, British Journal of Cancer.

P. Hersey, A. Edwards, W. McCarthy, 1980, International journal of cancer.

Relationship of natural killer-cell activity to rhesus antigens in man.

P. Hersey, A. Edwards, H. Shaw, 1979, British Journal of Cancer.

Sequential studies of melanoma leukocyte-dependent antibody activity in melanoma patients.

P. Hersey, A. Edwards, W. McCarthy, 1978, European journal of cancer.

Relationship of cell-mediated cytotoxicity against melanoma cells to prognosis in melanoma patients.

A. Edwards, W. McCarthy, G. Milton, 1978, British Journal of Cancer.

Phase II study of vaccinia melanoma cell lysates (VMCL) as adjuvant to surgical treatment of stage II melanoma

P. Hersey, A. Edwards, M. Macdonald, 1986, Cancer Immunology, Immunotherapy.

Characterization of mononuclear effector cells in human blood.

P. Hersey, A. Edwards, J. Edwards, 1976, Clinical and experimental immunology.

ANTIBODY-DEPENDENT, CELL-MEDIATED CYTOTOXICITY AGAINST MELANOMA CELLS INDUCED BY PLASMAPHERESIS

P. Hersey, J. Isbister, A. Edwards, 1976, The Lancet.

Western blot analysis of serological responses following immunization with vaccinia viral lysates of melanoma cells

P. Hersey, A. Edwards, H. Werkman, 1990, International journal of cancer.

Prognostic significance of expression of antigens on melanoma cells

J. Werkmeister, P. Hersey, A. Edwards, 1980, Cancer Immunology, Immunotherapy.

Evidence that treatment with vaccinia melanoma cell lysates (VMCL) may improve survival of patients with stage II melanoma

P. Hersey, A. Coates, A. Edwards, 1987, Cancer Immunology, Immunotherapy.

Prognostic significance of leukocyte-dependent antibody activity in melanoma patients.

P. Hersey, A. Edwards, W. McCarthy, 1983, Journal of the National Cancer Institute.

HIV-1 Variation Diminishes CD4 T Lymphocyte Recognition

Miles P. Davenport, R. Phillips, M. Davenport, 1998, The Journal of experimental medicine.

Effect of isoprinosine on natural killer cell activity of blood mononuclear cells in vitro and in vivo.

P. Hersey, A. Edwards, 1984, International journal of immunopharmacology.

Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants

Sarah Rowland-Jones, Susan Daenke, Andrew J. McMichael, 1994, Nature.

Rapid HIV disease progression following superinfection in an HLA-B*27:05/B*57:01-positive transmission recipient

Todd M. Allen, O. Pybus, P. Goulder, 2018, Retrovirology.

Efficacious Early Antiviral Activity of HIV Gag- and Pol-Specific HLA-B*2705-Restricted CD8+ T Cells

S. Buus, J. Prado, R. Phillips, 2010, Journal of Virology.

Differential Selection Pressure Exerted on HIV by CTL Targeting Identical Epitopes but Restricted by Distinct HLA Alleles from the Same HLA Supertype1

B. Walker, J. Mullins, C. Brander, 2006, The Journal of Immunology.

Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA

Andrew K. Sewell, Karina Yusim, Bette Korber, 2005, The Journal of experimental medicine.

HIV evolution: CTL escape mutation and reversion after transmission

Todd M. Allen, T A Roach, M. Altfeld, 2004, Nature Medicine.

Immunological effects of recombinant interferon alfa‐2a in patients with disseminated melanoma

P. Hersey, A. Coates, A. Edwards, 1986, Cancer.

Immunogenic HIV variant peptides that bind to HLA-B8 can fail to stimulate cytotoxic T lymphocyte responses.

P. Klenerman, A. Edwards, P. Giangrande, 1995, Journal of immunology.

Nef-Specific CD8+ T Cell Responses Contribute to HIV-1 Immune Control

D. Heckerman, B. Walker, T. Ndung’u, 2013, PloS one.

Differential Immunodominance Hierarchy of CD8+ T-Cell Responses in HLA-B*27:05- and -B*27:02-Mediated Control of HIV-1 Infection

M. Carrington, B. Walker, M. John, 2017, Journal of Virology.

Differential Immunodominance Hierarchy of CD8+ T-Cell Responses in HLA-B*27:05- and -B*27:02-Mediated Control of HIV-1 Infection

M. Carrington, B. Walker, M. John, 2017, Journal of Virology.

Heterosexual transmission of human immunodeficiency virus type 1 variants associated with zidovudine resistance.

P. Klenerman, B. Larder, A. Edwards, 1994, The Journal of infectious diseases.

Immunodominant cytomegalovirus-specific CD8+ T-cell responses in sub-Saharan African populations

S. Buus, P. Goulder, A. Edwards, 2017, PloS one.

Relationship between natural killer cell activity and histological features of lymphocyte infiltration and partial regression of the primary tumor in melanoma patients.

P. Hersey, A. Edwards, V. McGovern, 1982, Cancer research.

Effects of recombinant leukocyte interferon (rIFN-alpha A) on tumour growth and immune responses in patients with metastatic melanoma.

P. Hersey, A. Coates, A. Edwards, 1985, British Journal of Cancer.

Effects of cigarette smoking on the immune system: Follow‐up studies in normal subjects after cessation of smoking

P. Hersey, A. Edwards, D. Prendergast, 1983, The Medical journal of Australia.

Identification of a novel HLA-A24-restricted cytotoxic T-lymphocyte epitope within HIV-1 Nef.

R. Phillips, P. Goulder, A. McMichael, 1997, AIDS.

Identification of a novel HLA-B*3501-restricted cytotoxic T lymphocyte epitope using overlapping peptides.

R. Phillips, P. Goulder, A. McMichael, 1997, AIDS.

Therapeutic immunization of highly active antiretroviral therapy-treated HIV-1-infected patients: safety and immunogenicity of an HIV-1 gag/poly-epitope DNA vaccine

S. Rowland-Jones, A. McMichael, A. Iversen, 2005, AIDS.

Deficient natural killer cell activity in a patient with Fanconi's anaemia and squamous cell carcinoma. Association with defect in interferon release.

P. Hersey, A. Edwards, J. Mcinnes, 1982, Clinical and experimental immunology.

No evidence for an association between natural killer cell activity and prognosis in melanoma patients.

P. Hersey, A. Edwards, W. McCarthy, 1983, Natural immunity and cell growth regulation.

Rapid HIV disease progression following superinfection in an HLA-B*27:05/B*57:01-positive transmission recipient

Todd M. Allen, O. Pybus, P. Goulder, 2018, Retrovirology.

Differential Immunodominance Hierarchy of CD8 (cid:2) T-Cell Responses in HLA-B * 27:05- and -B * 27:02-Mediated Control of HIV-1 Infection

B. Walker, M. John, S. Mallal, 2018 .

Differential Immunodominance Hierarchy of CD8 (cid:2) T-Cell Responses in HLA-B * 27:05- and -B * 27:02-Mediated Control of HIV-1 Infection

B. Walker, M. John, S. Mallal, 2018 .

Low natural-killer-cell activity in familial melanoma patients and their relatives.

P. Hersey, A. Edwards, M. Honeyman, 1979, British Journal of Cancer.

HIV-1 Variation Diminishes CD4 T Lymphocyte Recognition

M. Davenport, A. Edwards, G. Harcourt, 1998, The Journal of experimental medicine.